Home / Bupivacaine / Canada
CA ATC N01BB01 · updated 2 Nov 2026
Bupivacaine shortage in Canada
Is there a Bupivacaine shortage in Canada?
Yes. As of 2 Nov 2026, 8 Bupivacaine products are reported short in Canada, the first since 31 Jan 2018. The company estimate for the return is 31 Mar 2027. Main reason: manufacturing problem.
Also short in United States, Italy, Austria, Czechia, Sweden, New Zealand, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | MARCAINE (1x50mL GVL) | PFIZER CANADA INC | 31 Jan 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MARCAINE (10 x 10ML) | PFIZER CANADA INC | 21 Feb 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MARCAINE (10X10mL GVL) | PFIZER CANADA INC | 20 Mar 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MARCAINE (10X20mL GVL) | PFIZER CANADA INC | 30 Mar 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MARCAINE (10 x 20mL GVL) | PFIZER CANADA INC | 9 Jan 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MARCAINE (10 x 20ml vials) | PFIZER CANADA ULC | 30 Mar 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP (10 x 2mL vial / fiole) | OMEGA LABORATORIES LIMITED | 22 Jun 2026 | 31 Mar 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP (2mL) anticipated | FORMATIVE PHARMA INC. | 1 Dec 2026 | not given | Manufacturing problem Requirements related to complying with good manufacturing practices |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.